l General Information |
Product Name | Rolapitant |
General description | Rolapitant is a potent, selective and orally active neurokinin NK1 receptor antagonist. |
Synonym | Varubi; Sch 619734 |
Purity | ≥99.0%(HPLC) | CAS Number | 552292-08-7 |
Formula | C25H26F6N2O2 | Molecular Weight | 500.48 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
l Biological Information |
Biochem/Physiol
Actions | Rolapitant is an orally available antiemetic agent that is used to prevent cancer chemotherapy related nausea and vomiting. Rolapitant therapy has not been associated with serum enzyme elevations or with instances of clinically apparent liver injury with jaundice. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
